1607793-29-2

1607793-29-2 structure

Name: Faricimab
Chemical Name: Faricimab
CAS Number: 1607793-29-2
Molecular Formula: C₂₅H₃₀ClN₃O₂
Molecular Weight: 440.0
Catalog: Signaling Pathways Protein Tyrosine Kinase/RTK VEGFR
Create Date: 2022-08-12 12:18:38
Modify Date: 2026-07-08 15:57:16
Faricimab is a bispecific antibody targeting angiopoietin-2 and vascular endothelial growth factor-A (VEGF-A). Faricimab can be used for diabetic macular edema (DME) research[1].

Name	Faricimab

Description	Faricimab is a bispecific antibody targeting angiopoietin-2 and vascular endothelial growth factor-A (VEGF-A). Faricimab can be used for diabetic macular edema (DME) research[1].
Related Catalog	Research Areas >> Metabolic Disease Signaling Pathways >> Protein Tyrosine Kinase/RTK >> VEGFR
Target	Angiopoietin-2, VEGF-A[1]
References	[1]. Sahni J, et al. Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial. Ophthalmology. 2019 Aug;126(8):1155-1170.